BioGRID ORCS Featured Datasets
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revision Both sides next revision | ||
|
orcs:featured_screens [2020/04/20 15:34] biogridadmin [2017 Datasets] |
orcs:featured_screens [2020/04/20 15:36] biogridadmin [2019 Datasets] |
||
|---|---|---|---|
| Line 10: | Line 10: | ||
| * **[[https://orcs.thebiogrid.org/Dataset/210|Zhuang X et al.]]** - **Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ.** Frontiers in immunology. January, 2019. | * **[[https://orcs.thebiogrid.org/Dataset/210|Zhuang X et al.]]** - **Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ.** Frontiers in immunology. January, 2019. | ||
| * **[[https://orcs.thebiogrid.org/Dataset/114|Behan FM et al.]]** - **Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.** Nature. April 10, 2019. | * **[[https://orcs.thebiogrid.org/Dataset/114|Behan FM et al.]]** - **Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.** Nature. April 10, 2019. | ||
| + | * **[[https://orcs.thebiogrid.org/Dataset/152|MacLeod G et al.]]** - **Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.** Cell Reports. April 16, 2019 | ||
| ==== 2018 Datasets ==== | ==== 2018 Datasets ==== | ||